Omni-PAGE?預制膠(Hepes-Tris)
Omni-PAGE?Hepes-Tris Gels
本產品常溫運輸;4℃可保存18個月。切勿置于0℃以下,以免凝膠發生凍裂。
產品組分
產品(pin)特點
go
o穩定性高——采用(yong)自(zi)動(dong)化灌膠生產(chan)(chan)技(ji)術,確(que)保了(le)產(chan)(chan)品質量的高穩定性和重復性;
go
o晰——采用玻(bo)璃膠板,有(you)效減少蛋白(bai)非特異性吸附,使(shi)蛋白(bai)條帶(dai)更(geng)為(wei)尖銳,清晰;
go
o電泳快速——電(dian)泳時間短,在(zai)150V電(dian)壓下,電(dian)泳40~50min即(ji)可完成;
go
o操作簡便——膠夾打開極為輕松,只需用(yong)刀(dao)片在膠夾一(yi)側輕輕劃一(yi)下即可打開;
go
o通用性強——凝膠中不含SDS,可用于(yu)變性和非變性電(dian)泳(yong)(需使用非變性電(dian)泳(yong)液);
go
o兼容性強——兼容市場上主流(liu)的mini電泳(yong)槽,如Bio-Rad,Invitrogen,天能(neng)和君(jun)意東方(fang)等;
go
o種類多樣——提供多種濃度的均一(yi)膠和梯度膠。均一(yi)膠可選濃度:8%,10%,12%,15%。梯度膠可選濃度:4~15%,4~20%,8~20%。
產品簡介
goodOmni-PAGE?預制(zhi)膠(Hepes-Tris)是一(yi)款安全、快捷、高性能的(de)預制(zhi)聚丙烯(xi)酰胺凝(ning)膠,常用于PAGE和Western Blot檢測。本預(yu)制膠含有1.5cm高(gao)度的4%濃縮膠(jiao)。丙(bing)烯(xi)(xi)酰胺與(yu)甲(jia)叉雙丙(bing)烯(xi)(xi)酰胺的(de)比例為29:1,凝膠(jiao)厚度為1.5mm,加樣孔數為10孔/15孔,最大上樣量(liang)為60μL/30μL,膠板尺寸:寬×高×厚度為98×84×4.1mm;凝膠尺寸為:寬×高×厚度為81 × 74×1.5mm。
1. Mei, J., Zhou, W. J., Zhu, X. Y., Lu, H., Wu, K., Yang, H. L., ... & Wang, J. (2018). Suppression of autophagy and HCK signaling promotes PTGS2high FCGR3? NK cell differentiation triggered by ectopic endometrial stromal cells. Autophagy, 14(8), 1376-1397. (IF 16.016)
good2. Ji, L., Qian, W., Gui, L., Ji, Z., Yin, P., Lin, G. N., ... & Gao, W. Q. (2020). Blockade of β-Catenin–Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration. Cancer Research, 80(10), 2004-2016. (IF 12.701)
good3. LI, Jing, et al. Selenium Status in Diet Affects Acetaminophen-Induced Hepatotoxicity via Interruption of Redox Environment. Antioxidants & Redox Signaling, 2021, 34.17: 1355-1367.(IF 8.401)
good4. Li, J., Cheng, P., Li, S., Zhao, P., Han, B., Ren, X., ... & Lu, J. (2020). Selenium status in diet affects acetaminophen-induced hepatotoxicity via interruption of redox environment. Antioxidants and Redox Signaling, (ja). (IF 8.401)
good5. LIU, Suxian, et al. Uncovering the Mechanism of Curcuma in the Treatment of Ulcerative Colitis Based on Network Pharmacology, Molecular Docking Technology, and Experiment Verification. Evidence-Based Complementary and Alternative Medicine, 2021, 2021.(IF 2.629)